JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, T.
Right arrow Articles by Kono, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, T.
Right arrow Articles by Kono, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 259, Issue 21, 13117-13122, Nov, 1984

Insulin action on glucose transport in cardiac muscle

T Watanabe, MM Smith, FW Robinson and T Kono

The mechanism of insulin action on glucose transport in rat hearts was studied. The glucose transport activity was determined after reconstitution into egg lecithin liposomes. Isolated rat hearts were perfused in the presence or absence of insulin and homogenized. The homogenate was fractionated by differential and sucrose density gradient centrifugations. Two subcellular fractions, designated as Fractions P-5 and P-6, contained glucose transport activity. Both fractions were enriched with 5'-nucleotidase (commonly known as a plasma membrane marker) and UDP-Gal:N-acetylglucosamine galactosyltransferase (known as a Golgi marker). However, only Fraction P-5 was concentrated with the insulin receptor and ouabain-sensitive p- nitrophenylphosphatase (both plasma membrane markers). The sedimentation properties of the glucose transport activity in Fraction P-6 were considerably different from those of galactosyltransferase. Insulin added to the heart before homogenization increased the glucose transport activity in Fraction P-5 approximately 1.6-fold while decreasing the activity in Fraction P-6 to approximately 62% of the control. These results are interpreted as follows. Both Fractions P-5 and P-6 are heterogeneous; nevertheless, Fraction P-5, but not Fraction P-6, may be enriched with the plasma membrane, which is assumed to be associated with glucose transport activity. Fraction P-6 may be concentrated with the Golgi apparatus; however, the latter may not be the structure (or vesicles) to which (intracellular) glucose transport activity is associated. Insulin appears to increase the glucose transport activity in rat hearts, at least in part, by inducing translocation of the glucose transport mechanism from the unidentified vesicles (in Fraction P-6) to the plasma membrane (in Fraction P-5).
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. J. Miller, J. Li, K. M. Sinusas, G. D. Holman, and L. H. Young
Infusion of a biotinylated bis-glucose photolabel: a new method to quantify cell surface GLUT4 in the intact mouse heart
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1922 - E1928.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Kaneta, Y. Takai, Y. Kagaya, Y. Yamane, H. Wada, M. Yuki, R. Iwata, M. Tsujitani, S. Takahashi, and S. Yamada
Imaging of Ischemic but Viable Myocardium Using a New 18F-Labeled 2-Nitroimidazole Analog, 18F-FRP170
J. Nucl. Med., January 1, 2002; 43(1): 109 - 116.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. E. Botker, H. Wiggers, M. Bottcher, J. S. Christiansen, T. T. Nielsen, A. Gjedde, and O. Schmitz
Short-term effects of growth hormone on myocardial glucose uptake in healthy humans
Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1053 - E1059.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Depre, J.-L. J. Vanoverschelde, and H. Taegtmeyer
Glucose for the Heart
Circulation, February 2, 1999; 99(4): 578 - 588.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Depre, V. Gaussin, S. Ponchaut, Y. Fischer, J.-L. Vanoverschelde, and L. Hue
Inhibition of myocardial glucose uptake by cGMP
Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1443 - H1449.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. W. Brownsey, A. N. Boone, and M. F. Allard
Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms
Cardiovasc Res, April 1, 1997; 34(1): 3 - 24.
[Full Text] [PDF]


Home page
HypertensionHome page
J. R. Sowers
Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology
Hypertension, March 1, 1997; 29(3): 691 - 699.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1984 by the American Society for Biochemistry and Molecular Biology.